Report
Kambiz Yazdi ...
  • Liana Moussatos
  • Shveta Dighe

Weekly Symphony Health Estimates for INVELTYS™

Underlying
Kala Pharmaceuticals

Kala Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics using the company's proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company's MPPs are selectively-sized nanoparticles and have proprietary coatings enhancing the mobility of drug particles through mucus and preventing drug particles from becoming trapped and eliminated by mucus. The company's product candidates include treatments for post-operative inflammation and pain following ocular surgery, temporary relief of the signs and symptoms of dry eye disease and retinal diseases.

Provider
Wedbush
Wedbush

Since our founding in 1955, Wedbush has been a leader in the financial industry providing our clients with a wide range of services; including institutional sales, correspondent clearing services, equity research, corporate and municipal finance, equity market making, fixed income trading, prime brokerage, and wealth management. Headquartered in Los Angeles, with 100 registered offices, the firm focuses on dedicated service, client financial safety, continuity, and advanced technology.

Analysts
Kambiz Yazdi

Liana Moussatos

Shveta Dighe

Other Reports on these Companies
Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe
Kambiz Yazdi ...
  • Liana Moussatos
  • Shveta Dighe
Other Reports from Wedbush
Other Reports from these Analysts
Kambiz Yazdi ...
  • Liana Moussatos
  • Shveta Dighe
Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe
Kambiz Yazdi ...
  • Liana Moussatos
  • Shveta Dighe

ResearchPool Subscriptions

Get the most out of your insights

Get in touch